Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use.
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.
How consent is or has been documented
The benefits of electronic consent documentation
Specific consent attributes, e.g. genetic testing
Handling consent requirements from different countries or institutions
Understanding consent for future use, including limitations and expirations
Learn more at https://www.q2labsolutions.com/labmatrix